The 3 patients who relapsed after imatinib treatment were all initially diagnosed with typical CML, with only the t(9;22) translocation and only the BCR/ABL1 fusion gene abnormality present. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.